Showing 4121-4130 of 5231 results for "".
- TODAY Show Feature Criticizes FDA on Sunscreenshttps://practicaldermatology.com/news/today-show-feature-criticizes-fda-sunscreens/2463127/The US Food and Drug Administration (FDA) is doing Americans a disservice by not approving many of the modern sunscreens that are commonly used in Europe, a representative from the Environmental Working Group (EWG) told the TODAY television show last week. “Currently, the US sunscreen mar
- Survey Shows Variability in Hyaluronidase Use Among Practitionershttps://practicaldermatology.com/news/survey-shows-variability-hyaluronidase-use-among-practitioners/2463109/New research suggests there are inconsistencies in the use of hyaluronidase (HYAL) for the treatment of adverse events with hyaluronic acid (HA) fillers, suggesting a need for standardized guidelines. "With the growing popularity and administration of HA fillers, there is likely to be a c
- PHOTOS: "Clearly Me" NYC Event Highlights Psoriasis Journeys of Patientshttps://practicaldermatology.com/news/photos-clearly-me-nyc-event-highlights-psoriasis-journeys-patients/2463107/AbbVie recently held a dynamic, photo-centric event at High Line Nine Galleries in New York City highlighting the psoriasis journeys of several patients through photographs. The exhibit, called Clearly Me, aimed to raise awareness about psoriatic disease by telling the stories of these p
- Study: Frequent Dermatologist Visits Boost Melanoma Survival Rateshttps://practicaldermatology.com/news/study-frequent-dermatologist-visits-boost-melanoma-survival-rates/2463097/New research suggests that patients with melanoma who engage in more frequent visits to the dermatologist show higher rates of survival. "Guidelines recommend that patients with melanoma undergo dermatologic examination at least annually," the authors wrote in the Journal of the American
- Consensus Statement Raises Awareness of CTCLhttps://practicaldermatology.com/news/consensus-statement-raises-awareness-ctcl/2463052/Kyowa Kirin, Inc. announced the publication of a patient-focused global consensus statement developed in collaboration with patient advocacy groups, calling on all healthcare authorities, hospitals, and clinicians to undertake 12 specific actions to enhance awareness, diagnosis, care, and support
- Novel Species and Drug Resistance Found in Skin Infectionshttps://practicaldermatology.com/news/novel-species-and-drug-resistance-found-skin-infections/2463021/A recent study highlighted growing concerns within the dermatological community regarding an increase in treatment-resistant fungal strains. Researchers from The University of Texas Health Science Center at San Antonio focused their investigation on dermatophytes, a group of fungi respons
- LEO Pharma Announces Topline Results of Phase 3 Trial in China for Plaque Psoriasis Treatment Enstilarhttps://practicaldermatology.com/news/leo-pharma-announces-topline-results-phase-3-trial-china-plaque-psoriasis-treatment-enstilar/2463007/LEO Pharma announced results from the Enstilar phase 3 trial in China in adult patients living with stable plaque psoriasis. The trial is a phase 3, randomised, investigator-blind, active controlled, parallel group, multicenter trial comparing the efficacy and safety of once daily Enstila
- Fish Residues Could Supply Collagenhttps://practicaldermatology.com/news/fish-residues-could-supply-collagen/2462980/Researchers in Norway believe fish residues can supplement current sources of raw materials for collagen and gelatin, according to a Phys.org article. A project called SUPREME, headed by the Norwegian science institute SINTEF Ocean in collaboration with Norwegian university NTNU and the T
- Acne Vulgaris Market Projected to Eclipse $10 Billion by 2034https://practicaldermatology.com/news/acne-vulgaris-market-projected-eclipse-10-billion-2034/2462961/The acne vulgaris market reached a value of US$ 7.0 Billion in 2023 and is anticipated to grow at a CAGR of 3.23% to more than $10 billion by 2034, according to a report by the IMARC Group. The rising popularity of light-based and laser therapies is partially responsible for this growth,
- Study: OTC Ointment Effective for Hydration and Wound Healing after Dermatologic Procedureshttps://practicaldermatology.com/news/otc-ointment-effective-hydration-wound-headling-dermatologic-procedures/2462940/Results from a two-study analysis in the Journal of Drugs in Dermatology suggested efficacy for an over-the-counter healing ointment (HO; Cetaphil Healing Ointment, Galderma Laboratories, LP, Dallas) in improving skin hydration and wound healing outcomes following dermatologic procedures